What laboratory findings are concerning for diabetic ketoacidosis?

Laboratory Findings Concerning for Diabetic Ketoacidosis

The diagnostic laboratory triad for DKA consists of: plasma glucose ≥250 mg/dL, arterial pH <7.3, serum bicarbonate <15 mEq/L, and positive serum or urine ketones with an anion gap ≥10 mEq/L 1.

Core Diagnostic Laboratory Values

The severity of DKA can be stratified based on specific laboratory thresholds 1:

Mild DKA

• Plasma glucose: ≥250 mg/dL
• Arterial pH: 7.25–7.30
• Serum bicarbonate: 15–18 mEq/L
• Anion gap: ≥10 mEq/L
• Ketones: Positive (serum or urine)
• Mental status: Alert

Moderate DKA

• Plasma glucose: ≥250 mg/dL
• Arterial pH: 7.00–7.24
• Serum bicarbonate: 10–15 mEq/L
• Anion gap: ≥12 mEq/L
• Ketones: Positive
• Mental status: Alert to drowsy

Severe DKA

• Plasma glucose: ≥250 mg/dL
• Arterial pH: <7.00
• Serum bicarbonate: <10 mEq/L
• Anion gap: ≥12 mEq/L
• Ketones: Positive
• Mental status: Stupor to coma

Essential Initial Laboratory Panel

When DKA is suspected, obtain the following immediately 1:

• Arterial blood gas (for pH and bicarbonate)
• Plasma glucose
• Serum ketones (β-hydroxybutyrate preferred) or urine ketones
• Complete metabolic panel with calculated anion gap [formula: Na - (Cl + HCO₃)]
• Effective serum osmolality [formula: 2(measured Na) + glucose/18]
• Blood urea nitrogen and creatinine
• Complete blood count with differential
• Urinalysis with urine ketones
• Electrocardiogram

Critical Nuances About Ketone Measurement

β-hydroxybutyrate (βOHB) measurement in blood is superior to nitroprusside-based ketone tests for both diagnosis and monitoring of DKA 2. This distinction is crucial because:

• The nitroprusside reaction detects acetoacetate and acetone but not βOHB, which is the predominant ketone in DKA
• During successful DKA treatment, βOHB decreases while acetoacetate may paradoxically increase, making nitroprusside tests misleading for monitoring therapy 2
• Point-of-care βOHB testing at triage shows 98% sensitivity and 85% specificity for DKA diagnosis at a threshold of ≥1.5 mmol/L 3

Euglycemic DKA: A Critical Pitfall

Recent guidelines have de-emphasized hyperglycemia as an absolute requirement because of increasing euglycemic DKA, particularly with SGLT2 inhibitor use 4. In these cases:

• Glucose may be <250 mg/dL or even normal
• Metabolic acidosis with elevated ketones remains present
• The diagnosis still requires: pH <7.3, bicarbonate <18 mEq/L, anion gap >10 mEq/L, and elevated ketones
• SGLT2 inhibitors modestly increase DKA risk in type 2 diabetes and substantially increase risk in type 1 diabetes 4

Additional Laboratory Findings

Electrolyte Abnormalities

Hyperkalemia occurs in 32.5% of DKA patients at presentation despite total body potassium depletion 5. This reflects:

• Hemoconcentration from dehydration
• Transcellular potassium shifts from acidosis and insulin deficiency
• Impaired renal function (eGFR negatively correlates with serum potassium, r = -0.378)

Corrected sodium should be calculated: for each 100 mg/dL glucose above 100 mg/dL, add 1.6 mEq/L to the measured sodium 1.

Renal Function

• Elevated BUN and creatinine from prerenal azotemia
• Decreased eGFR correlates with electrolyte abnormalities 5

Additional Tests to Consider

When clinically indicated 1, 4:

• Amylase and lipase (pancreatitis as precipitant or complication)
• Hepatic transaminases (hepatic steatosis)
• Troponin and creatine kinase (cardiac ischemia)
• Blood and urine cultures (infection as precipitant)
• Chest radiography (pneumonia)
• HbA1c (glycemic control assessment)

Differential Diagnosis Considerations

Not all ketoacidosis is DKA 1:

• Starvation ketosis: Glucose rarely >250 mg/dL, bicarbonate usually ≥18 mEq/L
• Alcoholic ketoacidosis: Normal to low glucose (may be hypoglycemic), profound acidosis possible
• Both conditions show positive ketones but lack the hyperglycemia typical of DKA

Monitoring During Treatment

Resolution of DKA is marked by 2:

• pH >7.3
• Bicarbonate ≥15 mEq/L
• Anion gap <12 mEq/L
• Reduction in blood βOHB (if measured)

Serial monitoring should include glucose every 1 hour, electrolytes and venous pH every 2-4 hours until resolution 1.